50 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Author: Lisa Levin | January 08, 2020 09:31am

Gainers

Midatech Pharma, Inc. (NASDAQ:MTP) stock moved upwards by 93.8% to $1.32 during Wednesday's pre-market session.
InVivo Therapeutics Hldg, Inc. (NASDAQ:NVIV) stock rose 31.0% to $0.38.
Applied Therapeutics, Inc. (NASDAQ:APLT) stock surged 25.0% to $32.69.
Verastem Oncology, Inc. (NASDAQ:VSTM) shares moved upwards by 15.1% to $1.45.
vTv Therapeutics, Inc. (NASDAQ:VTVT) stock moved upwards by 6.5% to $1.89.
Bio-Path Holdings, Inc. (NASDAQ:BPTH) stock rose 5.7% to $8.30. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $25.00.
BioNTech, Inc. (NASDAQ:BNTX) stock increased by 5.1% to $45.55. The most recent rating by Wolfe Research, on November 05, is at Outperform, with a price target of $21.00.
Personalis, Inc. (NASDAQ:PSNL) stock surged 5.0% to $11.45. The most recent rating by Morgan Stanley, on November 15, is at Overweight, with a price target of $16.00.
CannTrust Holdings, Inc. (NYSE:CTST) shares increased by 4.8% to $1.09.
Xenetic Biosciences, Inc. (NASDAQ:XBIO) stock increased by 4.8% to $1.54.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares rose 4.4% to $0.71.
Kala Pharmaceuticals, Inc. (NASDAQ:KALA) stock increased by 4.4% to $4.50. According to the most recent rating by Bank of America, on December 17, the current rating is at Neutral.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) stock surged 4.0% to $0.58.
Akorn, Inc. (NASDAQ:AKRX) stock rose 4.0% to $1.30.
Vascular Biogenics, Inc. (NASDAQ:VBLT) stock rose 4.0% to $1.30.
Solid Biosciences, Inc. (NASDAQ:SLDB) shares moved upwards by 3.9% to $4.49. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
KemPharm, Inc. (NASDAQ:KMPH) shares moved upwards by 3.7% to $0.56. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares rose 3.7% to $2.54. The most recent rating by H.C. Wainwright, on December 23, is at Buy, with a price target of $18.00.
Guardion Health Sciences, Inc. (NASDAQ:GHSI) stock increased by 3.6% to $0.37.
Anavex Life Sciences, Inc. (NASDAQ:AVXL) shares moved upwards by 3.5% to $3.00.
SCYNEXIS, Inc. (NASDAQ:SCYX) stock increased by 3.3% to $0.93.
Kitov Pharma, Inc. (NASDAQ:KTOV) shares rose 3.1% to $0.82.
Microbot Medical, Inc. (NASDAQ:MBOT) stock surged 2.7% to $11.87. The most recent rating by H.C. Wainwright, on December 24, is at Buy, with a price target of $12.00.
Novan, Inc. (NASDAQ:NOVN) stock rose 2.7% to $0.77. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
DBV Technologies, Inc. (NASDAQ:DBVT) shares moved upwards by 2.5% to $11.44. The most recent rating by Citigroup, on December 16, is at Buy, with a price target of $14.00.

Losers

Genetic Technologies, Inc. (NASDAQ:GENE) stock declined 18.0% to $3.70 during Wednesday's pre-market session.
NeuroMetrix, Inc. (NASDAQ:NURO) shares declined 9.6% to $3.35.
Genprex, Inc. (NASDAQ:GNPX) shares decreased by 9.5% to $0.38.
ContraFect, Inc. (NASDAQ:CFRX) stock plummeted 9.0% to $0.78.
Ocugen, Inc. (NASDAQ:OCGN) stock fell 7.2% to $0.59. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock decreased by 6.8% to $0.22. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) shares decreased by 6.8% to $28.90. The most recent rating by Canaccord Genuity, on December 24, is at Buy, with a price target of $65.00.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) shares plummeted 6.5% to $0.82.
Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) shares decreased by 6.3% to $0.22.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) stock decreased by 5.8% to $55.85. The most recent rating by SunTrust Robinson Humphrey, on December 18, is at Hold, with a price target of $60.00.
Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) shares fell 5.4% to $0.19.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) stock plummeted 4.9% to $2.32. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) stock decreased by 4.9% to $0.48. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
Correvio Pharma, Inc. (NASDAQ:CORV) shares declined 4.9% to $0.39. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) stock plummeted 4.4% to $4.11.
Aethlon Medical, Inc. (NASDAQ:AEMD) stock decreased by 4.3% to $1.10.
Tyme Technologies, Inc. (NASDAQ:TYME) stock fell 4.0% to $1.68.
Proteostasis Therapeutics, Inc. (NASDAQ:PTI) stock decreased by 4.0% to $2.16.
Conatus Pharmaceuticals, Inc. (NASDAQ:CNAT) shares plummeted 3.9% to $0.41.
Cassava Sciences, Inc. (NASDAQ:SAVA) stock fell 3.5% to $7.43. The most recent rating by H.C. Wainwright, on December 06, is at Buy, with a price target of $6.00.
Acasti Pharma, Inc. (NASDAQ:ACST) stock declined 3.0% to $2.26. The most recent rating by B. Riley FBR, on November 18, is at Buy, with a price target of $8.00.
Cellect Biotechnology, Inc. (NASDAQ:APOP) stock declined 2.9% to $3.97.
NewLink Genetics, Inc. (NASDAQ:NLNK) shares declined 2.8% to $2.06.
Advaxis, Inc. (NASDAQ:ADXS) stock plummeted 2.3% to $1.27.
SeaSpine Holdings, Inc. (NASDAQ:SPNE) shares fell 2.2% to $12.75. According to the most recent rating by Wells Fargo, on December 12, the current rating is at Underweight.